KLK Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$820K Buy
7,388
+15
+0.2% +$1.58K 0.82% 39
2021
Q4
$763K Sell
7,373
-90
-1% -$10.4K 0.73% 39
2021
Q3
$935K Buy
7,463
+5,190
+228% +$672K 0.86% 38
2021
Q2
$282K Buy
+2,273
New +$285K 0.24% 50

Other funds holding MDT

KLK Capital Management's MDT Position: Q1 2022 in Review

KLK Capital Management increased its Medtronic (MDT) stake by 0.2% in Q1 2022, buying an estimated $1.58K and bringing the position to 7,388 shares worth $820K. The position accounts for 0.82% of the portfolio, ranked #39.

KLK Capital Management first reported a position in MDT in Q2 2021 and has held it in 4 quarters since. The position peaked at $935K in Q3 2021. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • KLK Capital Management held 7,388 shares of Medtronic worth $820K as of Q1 2022.
  • KLK Capital Management bought 15 Medtronic shares in Q1 2022, an estimated $1.58K.
  • Medtronic made up 0.82% of KLK Capital Management's portfolio in Q1 2022, its #39 holding.
  • KLK Capital Management first reported a position in Medtronic in Q2 2021 and has held it in 4 quarters since.
  • KLK Capital Management's Medtronic position peaked at $935K in Q3 2021.
  • 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on KLK Capital Management's 13F filing for Q1 2022, filed 29 Apr 2022.